MEKK1 Is Required for Inducible Urokinase-type Plasminogen Activator Expression
Open Access
- 1 February 2003
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (8) , 5941-5946
- https://doi.org/10.1074/jbc.m212363200
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Matrix Metalloproteinase Gelatinase B (MMP-9) Coordinates and Effects Epithelial RegenerationJournal of Biological Chemistry, 2002
- Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered miceActa Physiologica Scandinavica, 2001
- Cutaneous Wound HealingNew England Journal of Medicine, 1999
- Role of Matrix Metalloproteinases and Their Inhibition in Cutaneous Wound Healing and Allergic Contact HypersensitivityAnnals of the New York Academy of Sciences, 1999
- Role of MEKK1 in Cell Survival and Activation of JNK and ERK Pathways Defined by Targeted Gene DisruptionScience, 1998
- Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formationNature Genetics, 1997
- The urokinase-type plasminogen activator system in cancer metastasis: A reviewInternational Journal of Cancer, 1997
- The regulation of AP-1 activity by mitogen-activated protein kinasesPhilosophical Transactions Of The Royal Society B-Biological Sciences, 1996
- Differential Expression of Urokinase-Type Plasminogen Activator and Its Type-1 Inhibitor During Healing of Mouse Skin WoundsJournal of Investigative Dermatology, 1991
- Urokinase- and Tissue-Type Plasminogen Activators in Keratinocytes During Wound Reepithelialization In VivoJournal of Investigative Dermatology, 1988